Haemonetics
HAE
#2911
Rank
NZ$10.18 B
Marketcap
NZ$223.76
Share price
1.60%
Change (1 day)
70.21%
Change (1 year)

P/S ratio for Haemonetics (HAE)

P/S ratio as of November 2026 (TTM): 4.05

According to Haemonetics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.68. At the end of 2026 the company had a P/S ratio of 3.45.

P/S ratio history for Haemonetics from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.4517.86%
20252.923.05%
20242.84-16.97%
20233.42-3.09%
20223.5223.95%
20212.84-58.31%
20206.8217.74%
20195.798.1%
20185.3656.98%
20173.4148.04%
20162.3125.75%
20151.83-11.96%
20142.08-9.73%
20132.31-9.32%
20122.5418.34%
20112.15-7.06%
20102.314.99%
20092.20-10.4%
20082.46-24.66%
20073.2621.62%
20062.68-15.47%
20053.1829.18%
20042.4643.56%
20031.7110.31%
20021.55-44.95%
20012.82

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.61 63.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
3.43-15.20%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
5.42 33.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.17-71.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.82-30.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
4.61 13.79%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
4.31 6.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
1.73-57.27%๐Ÿ‡บ๐Ÿ‡ธ USA